In our study, peripheral GM-CSF B cell expression was much higher in RA patients compared to disease controls with systemic rheumatic diseases such as ANCA vasculitides and Sjögren syndrome, diseases where B cells are crucial to their pathogenesis. The gene discussed is CSF2; the disease is Sjogren syndrome.